Source: European Journal of Nuclear Medicine. Conference titles: European Association of Nuclear Medicine; World Federation of Nuclear Medicine and Biology. Unidade: FM
Assunto: MEDICINA NUCLEAR
ABNT
WATANABE, T et al. Primary hyperparathyroidism scintigraphic diagnosis: a comparative study between thallium-201 and sestamibi-TC-99M. European Journal of Nuclear Medicine. [S.l.]: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 09 nov. 2024. , 1998APA
Watanabe, T., Buchpiguel, C. A., Sapienza, M. T., COSTA, P., Guimarães, M. I. C. C., & Hironaka, F. H. (1998). Primary hyperparathyroidism scintigraphic diagnosis: a comparative study between thallium-201 and sestamibi-TC-99M. European Journal of Nuclear Medicine. Faculdade de Medicina, Universidade de São Paulo.NLM
Watanabe T, Buchpiguel CA, Sapienza MT, COSTA P, Guimarães MICC, Hironaka FH. Primary hyperparathyroidism scintigraphic diagnosis: a comparative study between thallium-201 and sestamibi-TC-99M. European Journal of Nuclear Medicine. 1998 ; 25( 8): 1111.[citado 2024 nov. 09 ]Vancouver
Watanabe T, Buchpiguel CA, Sapienza MT, COSTA P, Guimarães MICC, Hironaka FH. Primary hyperparathyroidism scintigraphic diagnosis: a comparative study between thallium-201 and sestamibi-TC-99M. European Journal of Nuclear Medicine. 1998 ; 25( 8): 1111.[citado 2024 nov. 09 ]